Webcast CME

Latest Content

 Filter Results
Specialty:
Length: (Optional)
Sort by: Latest Top Rated
Neuro Pathways Podcast Series - Adolescent Psychiatric Services: Managing an Increased Demand
3.58 / 4.00
Neuro Pathways Podcast Series - Adolescent Psychiatric Services: Managing an Increased Demand
Faculty:
CME: Yes
Length: 28 minutes
Release Date: 11/15/2022 12:00:00 AM
Expiration Date: 11/15/2023
Neuro Pathways Podcast Series: Mechanisms of Alzheimer's Disease Found Through the Post-Mortem Brain Autopsy Program
3.58 / 4.00
Neuro Pathways Podcast Series: Mechanisms of Alzheimer's Disease Found Through the Post-Mortem Brain Autopsy Program
Faculty:
CME: Yes
Length: 20 minutes
Release Date: 11/1/2022 12:00:00 AM
Expiration Date: 11/01/2023
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
3.5 / 4.00
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD; Robert Sandhaus, MD; Lauren Palange, MS
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
3.75 / 4.00
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Robert Sandhaus, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
3.71 / 4.00
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
Faculty: Umur Hatipoglu, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
3.5 / 4.00
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
3.5 / 4.00
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
Faculty: Thomas Gildea, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
3.67 / 4.00
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
Faculty: Virginia Clark, MD; Shreya Sengupta, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Liver-Affected Alphas: Case Study, Advanced Disease and Treatment
3.33 / 4.00
Liver-Affected Alphas: Case Study, Advanced Disease and Treatment
Faculty: Charlie Strange, MD; Jeff Teckman, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Portal Hypertension, Hepatitis Vaccines, and the Importance of Family Testing in Patients with Alpha-1 Antitrypsin Deficiency
3.85 / 4.00
Portal Hypertension, Hepatitis Vaccines, and the Importance of Family Testing in Patients with Alpha-1 Antitrypsin Deficiency
Faculty: Charlie Strange, MD; Jeff Teckman, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025